ASH 2018: Dr. Woyach on the Ibrutinib versus BR trial results and so much more

[bkoffman]

Hi

Today we published the 1st quarter’s CLL Society Tribune (cllsociety.org/quarter-1-20... that includes an interview with the principal investigator, Dr. Woyack that should put another nail in the coffin of chemo-immunotherapy for all but a very few circumstances.

The Ask the Doctor, Pharmacist and Lab Scientist are fecund with all your great questions and we have great articles from patients and a caregiver.

Whether you are a patient or a caregiver, please complete our Shared Decision Making survey. We want a good number of respondents so that we can publish our results to share with community hematologists.

We are also rebooting a CLL support group in San Diego with the first meeting this Wednesday and I’ll be at the NIH this Friday for our educational forum which we will also live stream.

If you missed it, I blogged on my 1 year anniversary of my receiving my CAR-T therapy and still having my CLL remain undetectable.

Stay strong.

We are all in this together.

Brian

Brian Koffman MDCM DCFP, DABFM, MS Ed

[Beattiem-UK]

As ever, thank you for sharing this information. It's very encouraging for this 70 year old on Ibrutinib in the UK. And thank you for always signing off with Stay strong...we are all in this together. It always makes me feel better.

Beattie